Fighting Parasitic Infections: Promise in Cyclic Peptides
NIH Director's Blog: Drug Discovery
APRIL 11, 2017
Before testing their peptides in animal models, they’ll continue to tinker with them in search of a version effective in disabling iPGM that might also make its way into cells more easily. Drug development is a notoriously long and arduous process, which too often ends in disappointment. 2017 Apr 3;8:14932. Nat Commun.
Let's personalize your content